MedTrace Logo

Elucidate Outcomes of Elective High-grade/Total Occlusion Intracranial Arteries Using Low-profile Self-expanding Stent

NCT05947994 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2024-07-08

No results posted yet for this study

Summary

Intracranial atherosclerotic disease (ICAD) is a high prevalent cause of stroke, especially in Asian population and can be categorized as either symptomatic (resulting in acute ischemic stroke) or asymptomatic. Treatment for patients who failed with optimal medical therapy (OMT) is still elucidating.

Conditions

Interventions

PROCEDURE

Intracranial stenting with Credo® stent

Symptomatic ischemic stroke patients were treated with Credo® Stent

Sponsors & Collaborators

  • Acandis GmbH

    collaborator INDUSTRY

  • Can Tho Stroke International Services Hospital

    lead OTHER

Principal Investigators

  • Cuong C Tran, PhD · Can Tho Stroke International Services General Hospital

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-12-31
Completion
2024-04-20

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05947994 on ClinicalTrials.gov